Eating Behaviours of Women with an Eating Disorder and Autism Spectrum Disorder
- Conditions
- Eating Disorders, Autism Spectrum Disorder
- Registration Number
- NL-OMON20463
- Lead Sponsor
- none
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 90
In order to be eligible to participate in this study, a subject must meet all of the following criteria: patients will be included if they are female and 18 years of age or older. For the ED and ASD group, patients need to have a diagnosis of either anorexia nervosa (AN), bulimia nervosa (BN), binge eating disorder (BED) or other specified feeding- or eating disorder (OSFED) and a comorbid ASD diagnosis. For the ED group, patients need to have one of the above mentioned ED diagnoses. For the ASD group, patients need to have an ASD diagnosis. Diagnoses are determined according to DSM-5 criteria by an experienced clinical professional (psychiatrist or clinical psychologist).
A potential subject who meets any of the following criteria will be excluded from participation in this study: For all groups, we exclude patients with level of education below basic primary education (NL: basisonderwijs), with mental retardation and insufficient knowledge of the Dutch language. Additionally, patients of the ASD group are not allowed to have (a history of) of one of the above mentioned eating disorders, unspecified feeding or eating disorder (UFED), Pica or avoidant restrictive food intake disorder (ARFID) and patients of the ED group are not allowed to have ASD or traits thereof as well as a diagnosis of ARFID or UFED.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Primary outcomes: Quantative data will be investigated by means of the outcomes of the questionnaires EDE-Q, NIAS, SWEAA and APEQ as main study parameters. Exploratory analyses will be conducted by comparing the three groups (ED, ED and ASD, ASD) with regard to the above mentioned outcomes by means of ANOVA’s. In case of significant main effects, simple main effect analyses will be conducted to obtain more information. All ANOVA’s will be performed with an alpha level of .05.
- Secondary Outcome Measures
Name Time Method Secondary outcomes: To investigate whether the primary study outcomes are related to general psychiatric complaints, neurocognitive functioning and quality of life, correlations between the following questionnaires will be conducted: EDE-Q, NIAS, SWEAA and APEQ with BSI, DFlex and MHQoL.